Friday, 21 July 2017

Janssen-Cilag's HIV drug gets EU regulatory panel's nod

(Reuters) - A European regulatory panel recommended granting approval to a treatment for HIV infection developed by Janssen-Cilag International, a unit of U.S. drugmaker Johnson & Johnson.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)